Welcome : Guest

Amarin Corporation Plc (Ireland) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Amarin Corporation Plc, which is principally involved in Biopharmaceuticals Business. Illustrated with 14 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-12198
Price: $700
Company Type: Public
Pages: 17
Date: November 2016
Market Data Tables: 14

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Pharmaceuticals......4
Table 1: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti-Infective, and Others......4
Special Treatment Drugs......5
Table 2: Special Treatment Drugs Market by Group in Vietnam (2015) - Percentage Share Breakdown by Value for Cardiovascular Group, Metabolism Group, Neurology, Sterilization Group and Others......5
Cardiology Therapeutics......6
Table 3: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......6
Table 4: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......7
Table 5: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......8
Omega-3 Fatty Acids......9
Table 6: Omega-3 Fatty Acids Market by Product Type in the US (2015) - Percentage Share Breakdown by Volume for Epanova, Lovaza, Vascepa, and Others......9
Cholestrol Prescriptions......10
Table 7: No. of Cholestrol Prescriptions in the US (2015-2020) in '000......10
Table 8: Cholesterol Prescriptions Market by Product in the US (2015) - Percentage Share Breakdown by Volume for Fibrates, Statins, and Others......11
Cardiology Therapeutics......12
Table 9: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......12
Table 10: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......13
Severe Hypertriglyceridemia......14
Table 11: Market Shares of Leading Prescription Drugs for the Treatment of Severe Hypertriglyceridemia in the US (2015) - Percentage Share Breakdown by Value for EpanoVa, Lovaza, Trilipix, Vascepa, and Others......14
High Triglyceridemia......15
Table 12: Market Shares of Leading Prescription Drugs for the Treatment of High Triglyceridemia in the US (2015) - Percentage Share Breakdown by Value for EpanoVa, Trilipix, Vascepa, and Others......15
Moderate Triglyceridemia......16
Table 13: Market Shares of Leading Prescription Drugs for the Treatment of Moderate Triglyceridemia in the US (2015) - Percentage Share Breakdown by Value for Niaspan & Advicor, Trilipix, and Others......16
Hypertriglyceridemia......17
Table 14: Market Shares of Leading Prescription Drugs for the Treatment of Hypertriglyceridemia in the US (2015) - Percentage Share Breakdown by Volume for Lovaza, Niaspan & Advicor, Trilipix, Vascepa, and Others......17